Source: BioPortfolio

Stem CentRx: The Last of Stemcentrx

The final implosion of the Stemcentrx deal is worth a note although I said a lot of what I have to say about it back in December. I want to especially emphasize two points I made back then &8211; first that the failure of this whole acquisition is diff...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Brian Slingerland's photo - Co-Founder & CEO of Stem CentRx

Co-Founder & CEO

Brian Slingerland

CEO Approval Rating

69/100

Read more